Spots Global Cancer Trial Database for patupilone
Every month we try and update this database with for patupilone cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma | NCT00715013 | Recurrent Gliob... | Patupilone | 18 Years - 80 Years | University of Zurich | |
| Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced Solid Tumors | NCT00426582 | Advanced Solid ... | Patupilone | 18 Years - | Novartis | |
| Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies. | NCT00426140 | Advanced Malign... Solid Tumors | Patupilone | 18 Years - | Novartis | |
| Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies | NCT00420615 | Solid Tumors | Patupilone and ... Patupilone + Mi... | 18 Years - | Novartis | |
| Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan | NCT00412789 | Tumors | Patupilone | 20 Years - | Novartis | |
| Dose-Escalation Study in Advanced Colon Cancer Patients | NCT00969046 | Colon Cancer | EPO906 (patupil... | 18 Years - | Novartis | |
| Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer | NCT00411528 | Metastatic Horm... | Patupilone prednisone docetaxel | 18 Years - | Novartis | |
| Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma | NCT00273312 | Hepatocellular ... | Patupilone | 18 Years - | Novartis | |
| Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer | NCT00262990 | Ovarian Cancer Fallopian Tube ... Peritoneal Neop... | EPO906 (Patupil... doxorubicin | 18 Years - | Novartis | |
| Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies. | NCT00426140 | Advanced Malign... Solid Tumors | Patupilone | 18 Years - | Novartis | |
| Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan | NCT00412789 | Tumors | Patupilone | 20 Years - | Novartis | |
| The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies | NCT00468260 | Advanced Malign... | Patupilone | 18 Years - | Novartis | |
| Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer | NCT00411528 | Metastatic Horm... | Patupilone prednisone docetaxel | 18 Years - | Novartis | |
| Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer | NCT00262990 | Ovarian Cancer Fallopian Tube ... Peritoneal Neop... | EPO906 (Patupil... doxorubicin | 18 Years - | Novartis | |
| Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy | NCT00407251 | Hormone Refract... | Patupilone | 18 Years - | British Columbia Cancer Agency | |
| Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension) | NCT00442741 | Solid Tumors | Patupilone Patupilone + Om... | 18 Years - | Novartis | |
| Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer | NCT00219297 | Brain Metastasi... Non-small Cell ... | Patupilone | 18 Years - | Novartis | |
| Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies. | NCT00426140 | Advanced Malign... Solid Tumors | Patupilone | 18 Years - | Novartis | |
| Phase I Study of Patupilone and RAD001 | NCT00496600 | Refractory Mali... | Patupilone RAD001 | 18 Years - | Rutgers, The State University of New Jersey |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
